Catheter Precision Inc. (NYSE AMERICAN: VTAK) Stock Information | RedChip

Catheter Precision Inc. (NYSE AMERICAN: VTAK)


$0.3420
+0.0120 ( +0.89% ) 0.2K

Catheter Precision Inc is engaged in design, manufacture and sale of new and innovative medical technologies primarily focused in the field of cardiac electrophysiology, or EP. The Company's primary product is the View into Ventricular Onset System (VIVO or VIVO System) which is a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. The VIVO system has achieved a CE Mark allowing it to be commercialized in the European Union and has been placed at several hospitals in Europe. Its newest product, the Surgical Vessel Closing Pressure Device (LockeT), is a suture retention device indicated for wound healing by distributing suture tension.

Market Data


Open


$0.3420

Previous close


$0.3300

Volume


0.2K

Market cap


$2.64M

Day range


$0.3390 - $0.3390

52 week range


$0.3110 - $8.4000

SEC Filings


Form Type Description Pages Date
def Proxies and info statements 8 Nov 25, 2024
pre Proxies and info statements 8 Nov 15, 2024
10-q Quarterly Reports 106 Nov 14, 2024
8-k 8K-related 17 Nov 14, 2024
3 Insider transactions 1 Nov 08, 2024
8-k/a 8K-related 18 Nov 04, 2024
8-k 8K-related 16 Oct 30, 2024
8-k 8K-related 18 Oct 25, 2024
3 Insider transactions 1 Sep 09, 2024
8-k 8K-related 23 Sep 06, 2024

Latest News